HOUSTON, Feb. 13, 2017 /PRNewswire/ -- The Texas Medical Center (TMC) Innovation Institute today welcomes 24 startups into its accelerator program—its largest class since the institute's inception—to introduce their health IT applications to the Houston health care market. This is the fourth installment of TMCx, a program that is designed to meet the needs of startups at every stage—from ideation to commercialization—and to lower the barriers of access to hospital stakeholders and key opinion leaders across the world's largest medical center.
This new cohort also includes three Australian companies from the TMC's new BioBridge health technology startup exchange program designed to create a global health ecosystem linking the two countries.
"The Texas Medical Center hosts more than eight million patient visits each year, with people coming to Houston from all over the world, so it is fitting that this new cohort includes the best of the best in digital health startups from several international locations," said Erik M. Halvorsen, Ph.D., director of the TMC Innovation Institute. "Our mission is to help these startups connect their promising technology to the leading minds in medicine and business in our network."
Companies accepted to the new TMCx digital health cohort include:
Arterys (San Francisco) – Automated, intelligent software that uses real-world clinical data to make imaging more accurate and data driven.
Avalon AI (London, England) – Machine learning to automatically measure key features from brain MRI scans to increase speed and accuracy of neuroradiology diagnosis.
Clipboard Health(San Francisco) – Online marketplace connecting nursing staff with medical systems for tailored job placement.
CNSDose (Melbourne, Australia) – Genomic solution to fast track finding the most suitable antidepressant.
ConsultLink (Houston) – Mobile workspace for care team members to streamline and improve patient care.
DOT (Ottawa, Canada) – Precise and effective wearable consumer devices that diagnose and treat neurobehavioral disorders.
Glidian (Palo Alto, Calif.) – Electronic portal that streamlines prior authorizations for medications and procedures.
Healthcoin (Portland, Ore.) – Blockchain-based incentives and data platform for diabetes prevention.
InContext Reporting (Houston) – Quality management and clinical decision support tools powered by cognitive computing.
Insight Rx (San Francisco) – Quantitative pharmacology and machine-learning enabled precision medicine platform.
Lantern (San Francisco) – Personalized programs that combine daily exercises and professional coaching to strengthen emotional well-being.
M&S Biotics (Scranton, Pa.) – Artificial Intelligence and RFID technology improve resource utilization and efficiency.
ManageUP PRM (Santa Clara, Calif.) – Communication and collaboration solution to improve the ability to deliver quality patient care.
Medable (Palo Alto, Calif.) – Provides a fast path to secure, HIPAA-compliant health care applications for researchers, startups, pharma, payers and academia.
Medifies (San Francisco) – Platform to improve the hospital waiting room experience by keeping families informed through real-time updates.
NeuroLex Laboratories (Atlanta) – Voice analysis platform to detect health conditions before advanced symptoms appear.
Oncomfort (Houston and Brussels, Belgium) – Virtual reality technology to help ease patients' stress, pain and anxiety during their medical journey.
Personify Care (Adelaide, Australia) – Mobile platform enabling clinical teams to monitor patient recovery beyond the hospital stay.
Psious (Barcelona, Spain) – Virtual reality immersion therapy for mental health disorders.
SensorRx (Houston) – Patient-centered application to improve outcomes for migraine sufferers.
Stroll Health (San Francisco) – EHR-integrated referral platform.
Vios Medical (Minneapolis and Bangalore, India) – Patient management information systems focusing on clinical workflow automation and remote patient care services.
Ward Medication Management (Melbourne, Australia) – Decision support analytics engine that provides evidence-based prescribing recommendations.
TMCx provides a comprehensive and practical curriculum to assist participating founders on their entrepreneurial path. Successful investors, entrepreneurs, subject-matter experts, industry professionals and hospital leaders guide each startup in the areas of intellectual property, product development, regulatory strategies, health policy, marketing, fundraising, contract negotiations and communications.
The 24 companies will present their final pitch to an audience of advisors, hospital stakeholders and investors as part of Demo Day on June 8. Information on that event will be forthcoming.
About TMCx TMCx is the Texas Medical Center's accelerator program housed in a 100,000-square-foot, state-of-the-art facility, designed to catapult the development of early-stage life science and digital health startups. TMCx is one of the core components of the Texas Medical Center's Innovation Institute and a major step in the Texas Medical Center's long-term plans to become one of the world's premiere life science commercialization clusters. TMCx provides entrepreneurs the essential resources for growth including office and meeting space, training curriculum and an extensive advisor network comprised of business and legal experts, health care professionals, executives and investors. The inaugural TMCx program launched in Spring 2015. The Innovation Institute programs also include the TMC Biodesign fellowship and TMCx+ incubator. Corporate residents include Johnson & Johnson Innovation's JLABS @ TMC and AT&T Foundry for Connected Health, as well as a partnership with Apple. For more information, visit www.tmcinnovation.org.
PR Contact Christen David Vice President of Communications [email protected] 713-791-8838